RxFinder.ai

Pilocarpine

Qlosi, Salagen, VUITY

Cholinergic Receptor Agonist

NADAC/unit $0.3486
No Shortage Tier 1: 41.0% PA Req: 0.9% 9 Manufacturers 22 ANDAs
vs. brand Qlosi: Generic saves up to 97% per unit

Active Shortages

2026-03-24 Discontinuation of the manufacture of the drug, AbbVie Inc.
2026-03-24 Discontinuation of the manufacture of the drug, AbbVie Inc.
2026-03-24 Discontinuation of the manufacture of the drug, AbbVie Inc.
2026-03-24 Discontinuation of the manufacture of the drug, AbbVie Inc.
2026-03-24 Discontinuation of the manufacture of the drug, AbbVie Inc.

Generic Manufacturers

ABBVIE INCADVANZ PHARMA (US) CORPAMNEAL EU LTDAUROBINDO PHARMA USA INCFDC LTDIMPAX LABORATORIES INCINNOGENIX LLCLANNETT CO INCORASIS PHARMACEUTICALS LTDPADAGIS US LLCRISING PHARMA HOLDINGS INCSANDOZ INCSOMERSET THERAPEUTICS LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Pilocarpinedrfinder.aiFind doctors who prescribe Pilocarpinerxnews.aiLatest news about Pilocarpine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.